LAVA Therapeutics

+$0.29 (+2.43%) Today
-$0.20 (-1.63%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell LVTX and other stocks, options, and ETFs commission-free!

About LVTX

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The firm develops next generation T-cell engaging bispecific antibodies to treat cancer.

CEO
Stephen Allen Hurly
Employees
31
Headquarters
Utrecht, Noord-Brabant
Founded
2016

LVTX Key Statistics

Market Cap
306.45M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
47.82K
High Today
$12.30
Low Today
$11.90
Open Price
$11.90
Volume
8.93K
52 Week High
$17.20
52 Week Low
$9.76

LVTX Earnings

Q1 FY21
Estimated
— per share
Actual
Expected May 18, Pre-Market

You May Also Like

LYTS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure